GSK moves towards clearance of two new drugs in China and Japan
(Alliance News) - GSK PLC on Thursday reported positive regulatory momentum in Japan and China, where two of its drugs have been accepted for review. Read More
| Price | 2,201.00p on 02-03-2026 at 06:00:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 2,230.00p |
| Sell | 1,900.00p |
| Last Trade: | Sell 75,074.00 at 2,186.92749p |
| Day's Volume: | 0 |
| Last Close: | 2,201.00p |
| Open: | 0.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 1,242.50p - 2,282.00p |
| Market Capitalisation: | £88.33b |
| VWAP: | 0.00p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 75,074 | 2,186.92749p | Negotiated Trade |
17:03:15 - 27-Feb-26 |
| Unknown* | -75,704 | 2,186.92749p | Correction Negotiated Trade |
17:03:15 - 27-Feb-26 |
| Sell* | 75,704 | 2,186.92749p | Negotiated Trade |
17:03:15 - 27-Feb-26 |
| Buy* | 4,640 | 2,200.78p | SI Trade Negotiated Trade |
16:47:08 - 27-Feb-26 |
| Buy* | 52 | 2,200.78p | SI Trade Negotiated Trade |
16:47:08 - 27-Feb-26 |
| Buy* | 3,875 | 2,200.78p | SI Trade Negotiated Trade |
16:46:49 - 27-Feb-26 |
| Buy* | 1,212 | 2,201.00p | Suspected BUY Trade |
16:40:24 - 27-Feb-26 |
| Buy* | 901 | 2,201.00p | Suspected BUY Trade |
16:40:24 - 27-Feb-26 |
| Buy* | 63,817 | 2,201.00p | SI Trade Negotiated Trade |
16:36:38 - 27-Feb-26 |
| Buy* | 412 | 2,201.00p | SI Trade |
16:36:37 - 27-Feb-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 27th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 26th Feb 2026 7:05 am | RNS | Linerixibat accepted for priority review in China |
| 26th Feb 2026 7:00 am | RNS | Bepirovirsen accepted for Japan regulatory review |
| 26th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 25th Feb 2026 4:54 pm | RNS | Director/PDMR Shareholding |
| 25th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 25th Feb 2026 7:00 am | RNS | GSK enters agreement to acquire 35Pharma |
| 25th Feb 2026 7:00 am | RNS | Transaction in Own Shares |
| 24th Feb 2026 3:30 pm | RNS | Director/PDMR Shareholding |